Igantia Announces Digital Initiative to Decode Longevity

Share Article

By crowdsourcing scientific data across the world, Igantia plans to decode human longevity by examining the biological clocks inherent to women.

Igantia Therapeutics Inc

Igantia Therapeutics, Inc.

There is a huge stigma associated with aging, particularly for women. However, at Igantia our work is exhibiting a tremendous power in the genetic code and biology of women."

Igantia, an emerging biotechnology and research company based in San Francisco, leads an international initiative to examine key biological milestones during a woman’s life in order to extend the human lifespan. Scientists at Igantia believe that better understanding of the biological clocks inherent to women, from the initiation of her menstrual cycle to her transition into menopause, they will reveal a possible mechanism for aging and, ultimately, extend the lifespan.

By recently announcing the upcoming launch of its international digital health initiative, Igantia will crowdsource vital data to curate research that will assist in the advance of medical technologies engineered to treat age related ailments in women, from hot flashes to poly-cystic ovary syndrome.

In honor of Mother’s Day, the biotechnology company will launch the first phase of the initiative: an Apple IOS and Android application that will allow users to track either their hot flash events during the menopausal transition or their menstrual dynamics, in real time.

Collected information will be used to aid in research critical to discovering the biological components that control human longevity. Igantia will also collect key information to assist in the development of biotechnologies with the launch of its first set of therapeutics, including the world’s first non-hormonal technologies for hot flashes.

“There is a huge stigma associated with aging, particularly for women. However, at Igantia our work is exhibiting a tremendous power in the genetic code and biology of women,” stated Igantia’s founder, Dr. Sohila Zadran. “The digital initiative will unite women from across the globe on their journey through aging milestones. It is our hope that through examining the female biology and crowdsourcing information in real time, we will unlock the components that control longevity.”

Igantia is encouraging women to embrace the process of aging by sharing advice and asking health related questions on social media with the hashtag #IAmFury.

About Igantia Therapeutics, Inc.
Igantia Therapeutics Inc., headquartered in San Francisco, CA, was founded in January 2015 by neuroscientist and bioengineer, Dr. Sohila Zadran. The company has a mission of developing biotechnologies for women and examining the female biological clock to discover the key genetic components that control the human life span. By using a modern social approach to science, Igantia is pioneering women’s health by utilizing their findings to unveil the biological power found in women. Igantia has also partnered with the Fogarty Institute of Innovation.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ryan Philemon
Bella Joseph PR
+1 (704) 996-0476
Email >
Visit website